BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23626764)

  • 41. Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications.
    Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
    Appl Immunohistochem Mol Morphol; 2014; 22(2):142-5. PubMed ID: 23958542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer.
    Shen C; Xiang M; Nie C; Hu H; Ma Y; Wu H
    Acta Otolaryngol; 2013 Nov; 133(11):1219-26. PubMed ID: 23837451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AB209630, a long non-coding RNA decreased expression in hypopharyngeal squamous cell carcinoma, influences proliferation, invasion, metastasis, and survival.
    Zhou J; Li M; Yu W; Li W; Wang J; Xiang X; Li G; Pan X; Lei D
    Oncotarget; 2016 Mar; 7(12):14628-38. PubMed ID: 26895099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
    Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
    PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of the expression of integrin β1, VEGF and MVD in hypopharyngeal squamous cell carcinoma.
    Hong YM; Gan WG; Xu ZH
    Genet Mol Res; 2014 Aug; 13(3):6455-65. PubMed ID: 25158264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of molecular signature of head and neck cancer stem-like cells.
    Shrivastava S; Steele R; Sowadski M; Crawford SE; Varvares M; Ray RB
    Sci Rep; 2015 Jan; 5():7819. PubMed ID: 25588898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells.
    Chen YL; Yen YC; Jang CW; Wang SH; Huang HT; Chen CH; Hsiao JR; Chang JY; Chen YW
    Sci Rep; 2021 Jan; 11(1):644. PubMed ID: 33436772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma.
    Ming XY; Fu L; Zhang LY; Qin YR; Cao TT; Chan KW; Ma S; Xie D; Guan XY
    Nat Commun; 2016 Dec; 7():13568. PubMed ID: 27924820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment of a monoclonal antibody against glycosylated CD271 specific for cancer cells in immunohistochemistry.
    Fujii K; Morita S; Mochizuki M; Shibuya-Takahashi R; Fujimori H; Yamaguchi K; Abe J; Yamazaki T; Imai T; Sugamura K; Yasuda J; Satoh K; Sato I; Saito-Koyama R; Fujishima F; Sasano H; Kato Y; Matsuura K; Asada Y; Tamai K
    Cancer Sci; 2022 Aug; 113(8):2878-2887. PubMed ID: 35343032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aberrant GRK6 promoter methylation is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
    Qiu X; Chen J; Zhang Z; You Y; Wang Z
    Oncol Rep; 2016 Feb; 35(2):1027-33. PubMed ID: 26718636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
    Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.
    Saltari A; Truzzi F; Quadri M; Lotti R; Palazzo E; Grisendi G; Tiso N; Marconi A; Pincelli C
    J Invest Dermatol; 2016 Oct; 136(10):2049-2058. PubMed ID: 27328305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of heterozygosity of tumor suppressor genes (p16, Rb, E-cadherin, p53) in hypopharynx squamous cell carcinoma.
    Sang-Hyuk Lee SH; Lee NH; Jin SM; Rho YS; Jo SJ
    Otolaryngol Head Neck Surg; 2011 Jul; 145(1):64-70. PubMed ID: 21493295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma.
    Liu A; Zhu J; Wu G; Cao L; Tan Z; Zhang S; Jiang L; Wu J; Li M; Song L; Li J
    Mol Cancer; 2017 Jun; 16(1):106. PubMed ID: 28633632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma.
    Toyoda M; Kaira K; Shino M; Sakakura K; Takahashi K; Takayasu Y; Tominaga H; Oriuchi N; Nikkuni O; Suzuki M; Iijima M; Tsukamoto N; Nagamori S; Kanai Y; Oyama T; Chikamatsu K
    Head Neck; 2015 Nov; 37(11):1569-74. PubMed ID: 24913970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of melanoma initiating cells: does CD271 have a future?
    Ballotti R
    Future Oncol; 2015; 11(11):1587-90. PubMed ID: 26043212
    [No Abstract]   [Full Text] [Related]  

  • 59. Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells.
    Yu CH; Yu CC
    PLoS One; 2014; 9(1):e87129. PubMed ID: 24475244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NANOG modulates stemness in human colorectal cancer.
    Zhang J; Espinoza LA; Kinders RJ; Lawrence SM; Pfister TD; Zhou M; Veenstra TD; Thorgeirsson SS; Jessup JM
    Oncogene; 2013 Sep; 32(37):4397-405. PubMed ID: 23085761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.